Piotr Ozieranski
University of Bath
H-index: 17
Europe-United Kingdom
Top articles of Piotr Ozieranski
Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: an observational study
Health Policy and Technology
2024/6/1
Delays in dealing with complaints against drug companies are growing, BMJ finds
2024/2/14
Shai Mulinari
H-Index: 16
Piotr Ozieranski
H-Index: 10
Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis
medRxiv
2024
Pharmacy users’ perceptions, awareness and future expectations of community pharmacy in England: a focus group study
International Journal of Pharmacy Practice
2024/1/1
Piotr Ozieranski
H-Index: 10
Matthew D Jones
H-Index: 10
Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
Plos one
2023/11/1
Piotr Ozieranski
H-Index: 10
Shai Mulinari
H-Index: 16
Professional stakeholders’ expectations for the future of community pharmacy practice in England: a qualitative study
BMJ open
2023/10/1
Piotr Ozieranski
H-Index: 10
Matthew D Jones
H-Index: 10
Unethical pharmaceutical marketing: a common problem requiring collective responsibility
bmj
2023/9/19
Shai Mulinari
H-Index: 16
Piotr Ozieranski
H-Index: 10
Professional and governmental policy on community pharmacy: A 10-year policy review and comparative analysis (2008–2017)
Exploratory Research in Clinical and Social Pharmacy
2023/9/1
Piotr Ozieranski
H-Index: 10
Matthew D Jones
H-Index: 10
OP158 Corporate taming of the precautionary principle: A case study of the European Commission’s work on the communication (2000)
2023/8/1
Piotr Ozieranski
H-Index: 10
Anna Gilmore
H-Index: 38
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal …
Arthritis Care & Research
2023/6
Dataset for" Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis"
2023/3/29
Piotr Ozieranski
H-Index: 10
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
Globalization and Health
2023/3/3
Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
BMJ open
2023/3/1
Piotr Ozieranski
H-Index: 10
Unethical pharmaceutical marketing: Authors’ reply to Fell
British Medical Journal
2023
Shai Mulinari
H-Index: 16
Piotr Ozieranski
H-Index: 10
Characteristics and distribution of scholarship donations from pharmaceutical companies to Japanese healthcare institutions in 2017: a cross-sectional analysis
International Journal of Health Policy and Management
2023
Tip of the iceberg? Country-and company-level analysis of drug company payments for research and development in Europe
International Journal of Health Policy and Management
2022/12
Piotr Ozieranski
H-Index: 10
Shai Mulinari
H-Index: 16
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals
2022/7
Piotr Ozieranski
H-Index: 10
Disclosure of pharmaceutical industry funding of patient organisations in Nordic countries: can industry self-regulation deliver on its transparency promise?
International Journal of Health Services
2022/7
Piotr Ozieranski
H-Index: 10
Shai Mulinari
H-Index: 16
How do institutional conflicts of interest between pharmaceutical companies and the healthcare sector become corrupt? A case study of scholarship donations between department …
Frontiers in Public Health
2022/1/3
Co-Authors
